Sanofi and Cipla enters into distribution partnership to expand reach of CNS portfolio in India
Cipla will be responsible for the distribution of Sanofi India's six CNS brands including Frisium
Cipla will be responsible for the distribution of Sanofi India's six CNS brands including Frisium
The report underscores significant advancements in healthcare delivery, showcasing how GenAI facilitates improved diagnostic accuracy, operational efficiency and patient engagement
The surgeons were able to remove the entire breast while preserving the nipple through tiny hidden incisions
Centhaquine is a resuscitative agent presently indicated for the treatment of hypovolemic shock by DGCI
Combination shows consistent benefit across prespecified post-progression outcomes
Hepatitis B infects over 40 million people in India
KarXT, Karuna’s lead asset, is a potential first-in-class treatment for Schizophrenia
Pharma Solutions operates 10 research and development and/or production sites globally
The approved product has an estimated market size of US$ 44.5 million for the twelve months ending January 2024
Subscribe To Our Newsletter & Stay Updated